Change history
17 May 2018
This article was published with the same DOI as a previous publication. A new DOI has been assigned and registered at Crossref, and has been corrected in the article.
Rights and permissions
About this article
Cite this article
Plasma HER2 and EGFR levels are prognostic factors in patients with prostate cancer. Nat Rev Clin Oncol 5, 64–65 (2008). https://doi.org/10.1038/ncponc0996x
Issue Date:
DOI: https://doi.org/10.1038/ncponc0996x
- Springer Nature Limited